Investment analysts at StockNews.com began coverage on shares of Lannett (NYSE:LCI – Get Rating) in a research report issued on Sunday. The brokerage set a “hold” rating on the stock.
Lannett Price Performance
NYSE:LCI opened at $0.92 on Friday. The firm has a market cap of $9.91 million, a PE ratio of -0.05 and a beta of 0.95. The firm has a 50 day simple moving average of $2.04 and a 200-day simple moving average of $2.14. Lannett has a 1-year low of $0.86 and a 1-year high of $3.72.
Lannett (NYSE:LCI – Get Rating) last released its earnings results on Wednesday, February 1st. The company reported ($1.36) EPS for the quarter, topping the consensus estimate of ($1.64) by $0.28. The firm had revenue of $80.89 million during the quarter, compared to analysts’ expectations of $72.98 million. As a group, sell-side analysts expect that Lannett will post -6.16 earnings per share for the current fiscal year.
Institutional Trading of Lannett
About Lannett
Lannett Co, Inc engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Trevose, PA.
Recommended Stories
- Get a free copy of the StockNews.com research report on Lannett (LCI)
- MarketBeat Week in Review – 4/3 – 4/7
- Costco Sales Disappoint, Markets Are Missing This Upside Driver
- First Republic Bank Is A Speculative Play, Here’s Why
- The WD-40 Company Bottoms With Reversal In Sight
- 3 Low-Cost Stock ETFs That Are Crushing It This Year
Receive News & Ratings for Lannett Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lannett and related companies with MarketBeat.com's FREE daily email newsletter.